Table 1.

Summary of wavelengths reported to generate SSBs and base lesions.

Wavelength	Damage Characterization	Proteins observed	References
337 nm	8-oxodG, 6,4PPs, CPDs γH2AX positive	FEN1, PARP-1, XRCC1	(6)
351 nm	γH2AX positive	FUS/TLS	(33)
364 nm	γH2AX negative	BRCA1, HMGN1, Pol β, XRCC1	(17, 18, 21, 26, 27, 37)
365 nm (low power)	γH2AX negative	CAF1-p150, LIGIII, PCNA, PNKP, Pol β XRCC1	(14, 19)
365 nm (high power)	γH2AX positive 8-oxodG	BRCA1, CAF1-p150, NBS1, NEIL1, NEIL2, NTH1, OGG1, PCNA, RAD52	(19)
365 nm with Psoralen	γH2AX positive	NEIL1	(70)
365 nm with Ro19-8022	8-oxodG	NEIL1, NEIL2, NTH1, OGG1, Pol β, XRCC1	(19)
405 nm	Low power, γH2AX negative 16-800 μW, 8-oxodG and γH2AX positive	FEN1, PCNA, Pol β, PNKP, XRCC1	(16, 43, 44)
405 nm with BrdU or Hoechst	8-oxodG, CPDs γH2AX positive	LIGI, LIGIII, OGG1, PARP-1, PARG, XRCC1	(12, 13, 15, 22-24, 41, 42)
405 nm with Ro19-8022	8-oxodG Negative for 6,4PPs, and CPDs	CSB, OGG1, XPC, XRCC1	(32, 69)
435 nm	γH2AX negative	XRCC1	(45)
488 nm	γH2AX positive Negative for 8-oxodG, 6,4PPs, and CPDs	ATM, LIGIII, PCNA, RPA XRCC1	(46)
514 nm with EtBr	8-oxodG γH2AX positive	XRCC1, HP1, OGG1	(50)
559 nm with Killer Red	γH2AX positive 8-oxodG	FEN1, HP1, MED1, NEIL1, NEIL2, NTH1, PARP-1, PCNA, XRCC1	(20)
750 nm with Hoechst	γH2AX positive Negative for 8-oxodG	XRCC1, OGG1, PARP-1, LIGIII, PNKP	(12)
768 nm	None reported	OGG1	(25)
800 nm	None reported	FEN1, PCNA	(61)